We address this question through investigation of the progressive nature of neurodegeneration in both invertebrate and ...

A recent study conducted by the Icahn School of Medicine at Mount Sinai provides one of the most thorough insights to date ...

This award strongly validates our approach to Alzheimer’s disease,” said Dr. Carmela Abraham, Chief Science Officer. “With NIH support, we are one step closer to helping patients suffering from this ...

A new study led by the Icahn School of Medicine at Mount Sinai offers one of the most comprehensive views yet of how brain ...

In Alzheimer’s disease, Hameroff says, scientists don’t know whether the microtubules disintegrate and release the tau or whether the tau falls off because of a malfunction that weakens the bond. The ...

A new study led by the Icahn School of Medicine at Mount Sinai offers one of the most comprehensive views yet of how brain ...

Each year, World Alzheimer’s Month is observed in September, with World Alzheimer’s Day marked on Sept. 21 to raise awareness ...

For decades, scientists believed Alzheimer’s was driven mainly by sticky protein plaques and tangles in the brain. Now Purdue ...

Over 7 million people live with Alzheimer’s in America, with 1 in 3 adults dying with Alzheimer’s or another form of dementia. Those are just some of the reasons why a walk is being held this weekend.

In a finding that could change the way Alzheimer's disease is treated, researchers have identified a brain biomarker that ...

In response to February 2025 TGA decision not to approve lecanemab as a treatment for people with early AD, in March 2025, Eisai requested a review by the Administrative Review Tribunal. As a result ...